about
Thunder and lightning: immunotherapy and oncolytic viruses collideThe characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseasesGeneration of recombinant antibody fragments that target canine dendritic cells by phage display technology.Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Trends in cancer immunotherapyHypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in miceAdministration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response.Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy.Current status and future applications of cellular therapies for cancer.Innate immune recognition of poxviral vaccine vectors.Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapyGeneration of induced pluripotent stem cells from mouse cancer cells.Lipid-laden dendritic cells fail to function.Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.Initiative action of tumor-associated macrophage during tumor metastasis.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
P2860
Q24597894-6C468936-ADC1-41B6-9559-7C0E21B7061BQ26852652-6F74846A-E531-4376-8A70-1501FBB9CA2CQ33994982-4FBAEE72-AD74-4C60-9E4F-8ACDAA4B72D5Q34022013-49C43806-3655-4B5D-A5FF-A8DB7910AAC3Q34052702-29B4A719-78EB-4FDF-8A1F-D0926B28543FQ34677940-A727A1F2-A0BA-4625-AC57-6D935DD3F5C1Q35572421-C0EEA14C-FD9E-43B7-9930-6623C8E7D893Q36024702-C6CF374A-2824-42A3-BE93-D76157208C19Q37381085-7FE5CF12-8EF9-4C29-9333-A0908DBD50CCQ37861216-2353E3DC-3E00-4102-B983-969D6C97FE23Q37944321-BF007DFC-0C74-4C41-AB0C-30FD53794AE6Q39547016-74F40AE7-2CEE-4F8C-B2E3-1B88135D2964Q41761209-6366986F-2F35-483B-AD01-A5C39493BD43Q42093293-9F9B35F6-D56F-4673-91F0-DC13B71D3399Q42395107-6F7131E0-86A5-4D1D-B922-D3F31D3672DCQ42921747-42893D71-6C8A-4F7A-832F-A3C492CBFC06Q44599389-C6150AF3-1F86-4EF0-AF7C-304010BDB7DBQ52694263-5E7A308B-6F9A-4FCD-A37E-B8A928F66DA1Q55174561-84DE4F76-9742-4B3F-A3E5-BCCBEBBF6264
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The evolving role of dendritic cells in cancer therapy.
@en
The evolving role of dendritic cells in cancer therapy.
@nl
type
label
The evolving role of dendritic cells in cancer therapy.
@en
The evolving role of dendritic cells in cancer therapy.
@nl
prefLabel
The evolving role of dendritic cells in cancer therapy.
@en
The evolving role of dendritic cells in cancer therapy.
@nl
P2093
P2860
P1476
The evolving role of dendritic cells in cancer therapy.
@en
P2093
A A Melcher
R J D Prestwich
P2860
P304
P356
10.1517/14712590903559830
P407
P577
2010-03-01T00:00:00Z